Wenyong Chen

5.0k total citations · 1 hit paper
65 papers, 3.9k citations indexed

About

Wenyong Chen is a scholar working on Molecular Biology, Hematology and Geriatrics and Gerontology. According to data from OpenAlex, Wenyong Chen has authored 65 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Hematology and 12 papers in Geriatrics and Gerontology. Recurrent topics in Wenyong Chen's work include Chronic Myeloid Leukemia Treatments (14 papers), Sirtuins and Resveratrol in Medicine (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Wenyong Chen is often cited by papers focused on Chronic Myeloid Leukemia Treatments (14 papers), Sirtuins and Resveratrol in Medicine (11 papers) and Histone Deacetylase Inhibitors Research (9 papers). Wenyong Chen collaborates with scholars based in United States, China and United Kingdom. Wenyong Chen's co-authors include Stephen B. Baylin, Michael Roth, Tim M. Townes, Hongfeng Yuan, Ravi Bhatia, Wei Gu, Ray-Whay Chiu Yen, David H. Wang, Jianyuan Luo and Zhiqiang Wang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Wenyong Chen

60 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses

2005 530 citations Wenyong Chen, David H. Wang et al. Cell profile →

Peers

Countries citing papers authored by Wenyong Chen

Since Specialization

Citations

This map shows the geographic impact of Wenyong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyong Chen more than expected).

Fields of papers citing papers by Wenyong Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyong Chen. The network helps show where Wenyong Chen may publish in the future.

Co-authorship network of co-authors of Wenyong Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyong Chen. A scholar is included among the top collaborators of Wenyong Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyong Chen. Wenyong Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sex-dependent differences in hematopoietic stem cell aging and leukemogenic potential 2024 ·Oncogene ·Chunxiao Zhang, (unknown), (unknown), (unknown), Xiwei Wu, Jinhui Wang, Richard W. Ermel, (unknown), Shiuan Chen, Wenyong Chen	4
2	Deciphering the pharmacological mechanism of Radix astragali for allergic rhinitis through network pharmacology and experimental validation 2024 ·Scientific Reports ·(unknown), Xi Tan, Jingwen Zhang, (unknown), (unknown), (unknown), Shaoqing Liu, (unknown), Wenyong Chen, (unknown), Yunying Li	6
3	Loss of SIRT1 inhibits hematopoietic stem cell aging and age-dependent mixed phenotype acute leukemia 2022 ·Communications Biology ·(unknown), Chunxiao Zhang, Charles Warden, Zheng Liu, Yate‐Ching Yuan, Chao Guo, Charles Wang, Jinhui Wang, Xiwei Wu, Richard W. Ermel, Steven Vonderfecht, Xiuli Wang, Christine E. Brown, Stephen J. Forman, Ya‐Ling Yang, M. James You, Wenyong Chen	15
4	An aging mouse model of human chronic myeloid leukemia 2021 ·Oncogene ·(unknown), Chunxiao Zhang, Zhiqiang Wang, (unknown), Steven Vonderfecht, Richard W. Ermel, Young Kim, Wenyong Chen	6
5	Erchen Plus Huiyanzhuyu Decoction Inhibits the Growth of Laryngeal Carcinoma in a Mouse Model of Phlegm‐Coagulation‐Blood‐Stasis Syndrome via the STAT3/Cyclin D1 Pathway 2020 ·Evidence-based Complementary and Alternative Medicine ·Xi Tan, (unknown), (unknown), Wei Huang, (unknown), Wenyong Chen, Chaojie Yang, Yunying Li	8
6	Chinese herbal medicine bi min fang for allergic rhinitis: protocol for a double-blind, double-dummy, randomized controlled trial 2019 ·Trials ·(unknown), (unknown), Xiaoshan Li, Qubo Chen, (unknown), Liming Lu, Hua Li, Caifeng Chen, Wenyong Chen, Yunying Li	2
7	HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia 2017 ·Leukemia ·(unknown), Danielle P. Johnson, Samuel Bennett, (unknown), (unknown), Simon S. Jones, Jeffrey R. Shearstone, Steven N. Quayle, Chengyin Min, Matthew Jarpe, Tim Mosbruger, Anthony D. Pomicter, Rodney R. Miles, Wenyong Chen, Kapil N. Bhalla, Patrick A. Zweidler‐McKay, Dennis C. Shrieve, Michael W. Deininger, Mahesh B. Chandrasekharan, Srividya Bhaskara	34
8	A Convenient Cell Culture Model for CML Acquired Resistance Through BCR-ABL Mutations 2016 ·Methods in molecular biology ·Zhiqiang Wang, Wenyong Chen	1
9	VISFATIN (NAMPT) Improves in Vitro IGF1-Induced Steroidogenesis and IGF1 Receptor Signaling Through SIRT1 in Bovine Granulosa Cells1 2016 ·Biology of Reproduction ·Maxime Reverchon, Christelle Ramé, (unknown), Wenyong Chen, Pascal Froment, Joëlle Dupont	72
10	ATRA-Induced Cellular Differentiation and CD38 Expression Inhibits Acquisition of BCR-ABL Mutations for CML Acquired Resistance 2014 ·PLoS Genetics ·Zhiqiang Wang, Zheng Liu, Xiwei Wu, Su Chu, Jinhui Wang, Hongfeng Yuan, (unknown), Yate‐Ching Yuan, Ravi Bhatia, Wenyong Chen	27
11	Sirtuins in Hematological Aging and Malignancy 2013 ·Critical Reviews™ in Oncogenesis ·(unknown), (unknown), Wenyong Chen	23
12	Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling 2012 ·Molecular Oncology ·Sangkil Nam, Anna Scuto, Fan Yang, Wenyong Chen, Sungman Park, Hwa‐Seung Yoo, Helmut König, Ravi Bhatia, Xinlai Cheng, (unknown), Gerhard Eisenbrand, Richard Jove	59
13	Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib 2012 ·Cancer Cell ·Ling Li, Lisheng Wang, Liang Li, Zhiqiang Wang, YinWei Ho, Tinisha McDonald, Tessa L. Holyoake, Wenyong Chen, Ravi Bhatia	327
14	SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells 2012 ·Oncogene ·Zhiqiang Wang, Hongfeng Yuan, Michael Roth, Jeremy M. Stark, Ravi Bhatia, Wenyong Chen	87
15	NAMPT overexpression in prostate cancer and its contribution to tumor cell survival and stress response 2010 ·Oncogene ·(unknown), Md Kamrul Hasan, (unknown), Hongfeng Yuan, (unknown), Wenyong Chen	201
16	BCR-ABL Gene Expression Is Required for Its Mutations in a Novel KCL-22 Cell Culture Model for Acquired Resistance of Chronic Myelogenous Leukemia 2009 ·Journal of Biological Chemistry ·Hongfeng Yuan, Zhiqiang Wang, (unknown), Wengang Chen, Qin Huang, Jiing‐Kuan Yee, Ravi Bhatia, Wenyong Chen	41
17	Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses breakdown → 2005 ·Cell ·Wenyong Chen, David H. Wang, Ray-Whay Chiu Yen, Jianyuan Luo, Wei Gu, Stephen B. Baylin	530
18	Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis 2004 ·Cancer Cell ·Wenyong Chen, Timothy K. Cooper, Cynthia A. Zahnow, Michael Overholtzer, Zhao Zhi-quan, Marc Ladanyi, Judith E. Karp, Nalan Gökgöz, Jay S. Wunder, Irene L. Andrulis, Arnold J. Levine, Joseph L. Mankowski, Stephen B. Baylin	130
19	Inactivation of Tumor Suppressor Genes: Choice Between Genetic and Epigenetic Routes 2004 ·Cell Cycle ·Wenyong Chen, Stephen B. Baylin	14
20	High expression of the hormone binding active extracellular domain (1–294) of rat lutropin receptor in Escherichia coli 1993 ·Molecular and Cellular Endocrinology ·Wenyong Chen, O.P. Bahl	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact